Springing out of a promising research breakthrough on Alzheimer’s disease, UW-Madison researcher Jeff Johnson has co-founded Mithridion Inc. in hopes of commercializing an Alzheimer’s-inhibiting drug.
Office of Strategic Communication
Springing out of a promising research breakthrough on Alzheimer’s disease, UW-Madison researcher Jeff Johnson has co-founded Mithridion Inc. in hopes of commercializing an Alzheimer’s-inhibiting drug.